{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:15:25Z","timestamp":1790738125639,"version":"4.1.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cellimm.2016.09.009","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T15:32:20Z","timestamp":1474039940000},"page":"27-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":244,"special_numbering":"C","title":["PD-1\/PD-L and autoimmunity: A growing relationship"],"prefix":"10.1016","volume":"310","author":[{"given":"Mohammad Reza","family":"Zamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Salmaninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Javan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.autrev.2011.10.004","article-title":"Are autoimmune diseases predictable?","volume":"11","author":"Tob\u00f3n","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1600-065X.2009.00769.x","article-title":"Yin-Yang of costimulation: crucial controls of immune tolerance and function","volume":"229","author":"Nurieva","year":"2009","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/156652412799218903","article-title":"The PD-1\/PD-L1 pathway in human pathology","volume":"12","author":"Saresella","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","article-title":"SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation","volume":"173","author":"Chemnitz","year":"2004","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0030","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0035","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1084\/jem.191.5.891","article-title":"Facilitation of \u03b2 selection and modification of positive selection in the thymus of PD-1\u2013deficient mice","volume":"191","author":"Nishimura","year":"2000","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0040","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI65325","article-title":"SHP-1 phosphatase activity counteracts increased T cell receptor affinity","volume":"123","author":"Hebeisen","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20051776","article-title":"Tissue expression of PD-L1 mediates peripheral T cell tolerance","volume":"203","author":"Keir","year":"2006","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"issue":"29","key":"10.1016\/j.cellimm.2016.09.009_b0055","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1073\/pnas.0307252101","article-title":"PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells","volume":"101","author":"Latchman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.cellimm.2016.09.009_b0060","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7\u2013H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion","volume":"5","author":"Dong","year":"1999","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0065","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.193.7.839","article-title":"B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells","volume":"193","author":"Tseng","year":"2001","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cellimm.2016.09.009_b0075","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0080","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4049\/jimmunol.170.3.1257","article-title":"Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production","volume":"170","author":"Brown","year":"2003","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0085","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/intimm\/8.5.773","article-title":"Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4\u2013CD8\u2013) thymocytes","volume":"8","author":"Nishimura","year":"1996","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.cellimm.2016.09.009_b0090","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.4049\/jimmunol.179.8.5064","article-title":"PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues","volume":"179","author":"Keir","year":"2007","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2016.09.009_b0095","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.4049\/jimmunol.171.9.4574","article-title":"Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4\/CD8 double-negative TCR-transgenic T cells","volume":"171","author":"Blank","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.immuni.2005.01.015","article-title":"Defective central tolerance induction in NOD mice: genomics and genetics","volume":"22","author":"Zucchelli","year":"2005","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.cellimm.2016.09.009_b0105","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/eji.200324270","article-title":"Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis","volume":"33","author":"Rodig","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ni1165","article-title":"Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4","volume":"6","author":"Probst","year":"2005","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.cellimm.2016.09.009_b0120","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1167\/iovs.05-1597","article-title":"Differential effects of costimulatory pathway modulation on corneal allograft survival","volume":"47","author":"Watson","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"13","key":"10.1016\/j.cellimm.2016.09.009_b0125","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0165-0378(93)90068-S","article-title":"Activation of circulating \u03b3\u03b4 T-lymphocytes by autologous sperm from men sensitized to sperm","volume":"25","author":"Munoz","year":"1993","journal-title":"J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0135","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1095\/biolreprod.107.063578","article-title":"Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma","volume":"78","author":"Dal Secco","year":"2008","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Guleria","year":"2005","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.cellimm.2016.09.009_b0145","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.4049\/jimmunol.1002031","article-title":"The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance","volume":"187","author":"D\u2019Addio","year":"2011","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0150","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1089\/jwh.2013.4462","article-title":"Role of environment and sex differences in the development of autoimmune diseases: a roundtable meeting report","volume":"22","author":"Mallampalli","year":"2013","journal-title":"J. Womens Health"},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/13697130903025449","article-title":"The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus","volume":"12","author":"Holroyd","year":"2009","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaci.2010.12.1087","article-title":"Current and novel therapeutics in the treatment of systemic lupus erythematosus","volume":"127","author":"Yildirim-Toruner","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0165","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.bor.0000245718.56770.a4","article-title":"The X chromosome and systemic sclerosis","volume":"18","author":"Selmi","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cellimm.2016.09.009_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00493","article-title":"FOXP3+ Treg cells and gender bias in autoimmune diseases","volume":"6","author":"Nie","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2016.09.009_b0175","first-page":"190.5","article-title":"PD-1 interaction with PD-L1 but not PD-L2 on B cells mediates protective effects of estrogen against EAE (P5176)","volume":"2013","author":"Bodhankar","year":"1945","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/intimm\/dxl151","article-title":"Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)","volume":"19","author":"Polanczyk","year":"2007","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nri.2015.1","article-title":"Regulatory T cell memory","volume":"16","author":"Rosenblum","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"13","key":"10.1016\/j.cellimm.2016.09.009_b0190","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med."},{"issue":"1 Suppl.","key":"10.1016\/j.cellimm.2016.09.009_b0195","article-title":"Blockade of surface bound TGF-\u03b2 on regulatory T cells abrogates suppression of effector T cell function within the tumor microenvironment (TUM2P. 1015)","volume":"194","author":"Budhu","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/PPO.0000000000000059","article-title":"Biochemical Signaling of PD-1 on T Cells and Its Functional Implications","volume":"20","author":"Boussiotis","year":"2014","journal-title":"Cancer J."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","article-title":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3","volume":"22","author":"Fontenot","year":"2005","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0215","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/eji.200838346","article-title":"TGF-\u03b2-induced Foxp3+ regulatory T cells rescue scurfy mice","volume":"38","author":"Huter","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0230","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm1517","article-title":"Loss of tumor suppressor PTEN function increases B7\u2013H1 expression and immunoresistance in glioma","volume":"13","author":"Parsa","year":"2007","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.cellimm.2016.09.009_b0240","doi-asserted-by":"crossref","first-page":"a007641","DOI":"10.1101\/cshperspect.a007641","article-title":"The pathogenesis and natural history of type 1 diabetes","volume":"2","author":"Atkinson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"11","key":"10.1016\/j.cellimm.2016.09.009_b0245","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni.1790","article-title":"Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR\u2013induced stop signal","volume":"10","author":"Fife","year":"2009","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2016.09.009_b0250","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/eji.200839103","article-title":"Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1","volume":"39","author":"Unger","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clim.2007.05.013","article-title":"Mechanisms of PDL1-mediated regulation of autoimmune diabetes","volume":"125","author":"Guleria","year":"2007","journal-title":"Clin. Immunol."},{"issue":"33","key":"10.1016\/j.cellimm.2016.09.009_b0260","doi-asserted-by":"crossref","first-page":"11823","DOI":"10.1073\/pnas.0505497102","article-title":"Establishment of NOD-Pdcd1-\/-mice as an efficient animal model of type I diabetes","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cellimm.2009.04.006","article-title":"Altered availability of PD-1\/PD ligands is associated with the failure to control autoimmunity in NOD mice","volume":"258","author":"Yadav","year":"2009","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"198","author":"Ansari","year":"2003","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.cellimm.2016.09.009_b0275","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.4049\/jimmunol.177.12.8291","article-title":"Cutting edge: programed death (PD) ligand-1\/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens","volume":"177","author":"Martin-Orozco","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0280","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.4049\/jimmunol.1101390","article-title":"CD4+ type II NKT cells mediate ICOS and programmed death-1\u2013dependent regulation of type 1 diabetes","volume":"188","author":"Kadri","year":"2012","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0285","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2337\/db07-1260","article-title":"Protective Role of Programmed Death 1 Ligand 1 (PD-L1) in Nonobese Diabetic Mice The Paradox in Transgenic Models","volume":"57","author":"Wang","year":"2008","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0290","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1172\/JCI19210","article-title":"Local expression of B7\u2013H1 promotes organ-specific autoimmunity and transplant rejection","volume":"113","author":"Subudhi","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0733-8619(18)30061-6","article-title":"The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis","volume":"13","author":"Owens","year":"1995","journal-title":"Neurol. Clin."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0300","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09273940802491884","article-title":"Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis","volume":"17","author":"Chen","year":"2009","journal-title":"Ocular Immunol. Inflammation"},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.20022119","article-title":"Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis","volume":"198","author":"Salama","year":"2003","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0315","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2006.10.006","article-title":"PD-1\/PD-L1, but not PD-1\/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis","volume":"182","author":"Carter","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0320","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1402","article-title":"Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE","volume":"12","author":"Liu","year":"2006","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jnr.22181","article-title":"Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis","volume":"88","author":"Wang","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0330","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00019052-200206000-00001","article-title":"Pathogenesis of multiple sclerosis: an update on immunology","volume":"15","author":"Hemmer","year":"2002","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"10.1016\/j.cellimm.2016.09.009_b0335","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+ CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J. Immunol."},{"issue":"43","key":"10.1016\/j.cellimm.2016.09.009_b0340","doi-asserted-by":"crossref","first-page":"15434","DOI":"10.1073\/pnas.0404444101","article-title":"Myelin proteolipid protein-specific CD4+ CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis","volume":"101","author":"Reddy","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2016.09.009_b0345","series-title":"Generation and Effector Functions of Regulatory Lymphocytes: Novartis Foundation Symposium 252","article-title":"CD4+ CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo","author":"Baecher-Allan","year":"2003"},{"key":"10.1016\/j.cellimm.2016.09.009_b0350","article-title":"Downregulation of immunosuppressive molecules, PD-1 and PD-L1 but not PD-L2, in the patients with multiple sclerosis","author":"Javan","year":"2016","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"10","key":"10.1016\/j.cellimm.2016.09.009_b0355","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.175.10.6265","article-title":"Cutting edge: murine vascular endothelium activates and induces the generation of allogeneic CD4+ 25+ Foxp3+ regulatory T cells","volume":"175","author":"Krupnick","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0360","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0365","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1443-9573.2007.00287.x","article-title":"Management of inflammatory bowel disease in adults","volume":"8","author":"Katz","year":"2007","journal-title":"J. Digest. Dis."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0370","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1993.tb05997.x","article-title":"Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1\u03b2 by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn\u2019s disease","volume":"94","author":"Reinecker","year":"1993","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2016.09.009_b0375","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.4049\/jimmunol.177.9.5852","article-title":"Characterization of Foxp3+ CD4+ CD25+ and IL-10-secreting CD4+ CD25+ T cells during cure of colitis","volume":"177","author":"Uhlig","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0380","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/j.gastro.2004.02.004","article-title":"The expression and function of costimulatory molecules B7H and B7\u2013H1 on colonic epithelial cells","volume":"126","author":"Nakazawa","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0385","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/eji.200425109","article-title":"Regulation of murine chronic colitis by CD4+ CD25\u2013programmed death-1+ T cells","volume":"35","author":"Totsuka","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0390","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/eji.200737914","article-title":"Immunosenescent colitogenic CD4+ T cells convert to regulatory cells and suppress colitis","volume":"38","author":"Totsuka","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0395","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","article-title":"Experimental models of inflammatory bowel diseases","volume":"1","author":"Kiesler","year":"2015","journal-title":"CMGH Cell. Mol. Gastroenterol. Hepatol."},{"issue":"7077","key":"10.1016\/j.cellimm.2016.09.009_b0400","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2005","journal-title":"Nature"},{"issue":"7109","key":"10.1016\/j.cellimm.2016.09.009_b0405","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2016.09.009_b0410","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.oraloncology.2016.04.005","article-title":"Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma","volume":"57","author":"Kondo","year":"2016","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0415","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ncprheum0047","article-title":"Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis","volume":"1","author":"M\u00fcller-Ladner","year":"2005","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"11","key":"10.1016\/j.cellimm.2016.09.009_b0420","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2010.134684","article-title":"State-of-the-art: rheumatoid arthritis","volume":"69","author":"McInnes","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.cellimm.2016.09.009_b0425","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","article-title":"CD4+ CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis","volume":"172","author":"de Kleer","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0430","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.20217","volume":"50","author":"Keystone","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0435","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti\u2013TNF-\u03b1 therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-\u03b2","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0440","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.11063","article-title":"CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis","volume":"48","author":"Morgan","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0445","doi-asserted-by":"crossref","first-page":"R291","DOI":"10.1186\/ar1484","article-title":"The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+ CD25+ T cells","volume":"7","author":"Frey","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0450","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0455","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0460","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.cellimm.2016.09.009_b0465","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1136\/ard.2008.100768","article-title":"FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment","volume":"68","author":"Raghavan","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0470","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","article-title":"CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis","volume":"140","author":"M\u00f6tt\u00f6nen","year":"2005","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2016.09.009_b0475","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.4049\/jimmunol.177.12.8844","article-title":"Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis","volume":"177","author":"Wan","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0480","first-page":"1410","article-title":"CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid","volume":"30","author":"Hatachi","year":"2003","journal-title":"J. Rheumatol."},{"issue":"19","key":"10.1016\/j.cellimm.2016.09.009_b0485","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0024-3205(97)00480-3","article-title":"Collagen-induced arthritis, an animal model of autoimmunity","volume":"61","author":"Myers","year":"1997","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0490","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00296-009-1249-0","article-title":"The effects of PDL-Ig on collagen-induced arthritis","volume":"31","author":"Wang","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cellimm.2016.09.009_b0495","article-title":"Protective effects of Fc-fused PD-L1 on two different animal models of colitis","author":"Song","year":"2014","journal-title":"Gut"},{"issue":"S1","key":"10.1016\/j.cellimm.2016.09.009_b0500","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0505","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"S1","key":"10.1016\/j.cellimm.2016.09.009_b0510","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1002\/hep.21059","article-title":"Autoimmune hepatitis, from mechanisms to therapy","volume":"43","author":"Manns","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2016.09.009_b0515","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0520","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cellimm.2016.09.009_b0525","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1827.2007.02129.x","article-title":"Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease","volume":"57","author":"Oikawa","year":"2007","journal-title":"Pathol. Int."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0530","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2006.05.007","article-title":"PD-L1 is induced in hepatocytes by viral infection and by interferon-\u03b1 and-\u03b3 and mediates T cell apoptosis","volume":"45","author":"M\u00fchlbauer","year":"2006","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0535","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.01.002","article-title":"Dysregulated generation of follicular helper T cells in the spleen triggers fatal autoimmune hepatitis in mice","volume":"140","author":"Aoki","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0540","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/liv.12245","article-title":"Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis","volume":"34","author":"Ma","year":"2014","journal-title":"Liver Int."},{"issue":"13","key":"10.1016\/j.cellimm.2016.09.009_b0545","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/hepr.12305","article-title":"Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis","volume":"44","author":"Miyake","year":"2014","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0550","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/jgh.12340","article-title":"Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis","volume":"29","author":"Matsumoto","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellimm.2016.09.009_b0555","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1176653","article-title":"PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma","author":"Chen","year":"2016","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0560","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.20022235","article-title":"PD-1 inhibits antiviral immunity at the effector phase in the liver","volume":"198","author":"Iwai","year":"2003","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0565","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1572-0241.2006.00948.x","article-title":"Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases","volume":"102","author":"Mataki","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0570","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2016.09.009_b0575","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0580","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2007.12.014","article-title":"Restoration of HCV-specific T cell functions by PD-1\/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment","volume":"48","author":"Urbani","year":"2008","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0585","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0590","doi-asserted-by":"crossref","first-page":"e63818","DOI":"10.1371\/journal.pone.0063818","article-title":"A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection","volume":"8","author":"Gardiner","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0595","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1074-7613(04)00050-0","article-title":"B7\u2013H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes","volume":"20","author":"Dong","year":"2004","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0600","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/hep.20669","article-title":"Preferential loss of IL-2\u2013secreting CD4+ T helper cells in chronic HCV infection","volume":"41","author":"Semmo","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0605","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.193.3.297","article-title":"Impairment of CD4+ T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants","volume":"193","author":"Ciurea","year":"2001","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0610","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.21379","article-title":"In vivo immune modulatory activity of hepatic stellate cells in mice","volume":"44","author":"Chen","year":"2006","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.cellimm.2016.09.009_b0615","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et\u2019s disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0620","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1365-2133.2011.10274.x","article-title":"Altered expression of costimulatory molecules in Beh\u00e7et\u2019s disease according to clinical activity","volume":"164","author":"Sim","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"10.1016\/j.cellimm.2016.09.009_b0625","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"5502","key":"10.1016\/j.cellimm.2016.09.009_b0630","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0635","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jneuroim.2007.09.019","article-title":"Programmed Death-1: from gene to protein in autoimmune human myasthenia gravis","volume":"193","author":"Sakthivel","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0640","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.autrev.2014.01.006","article-title":"Diagnosis and classification of autoimmune uveitis","volume":"13","author":"Selmi","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.cellimm.2016.09.009_b0645","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1167\/iovs.06-0201","article-title":"CD4+ PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation","volume":"47","author":"Meng","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.cellimm.2016.09.009_b0650","first-page":"850","article-title":"Paradoxically decreased uveitis susceptibility in PD-L1\/L2 double knockout mice","volume":"56","author":"Ashki","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0655","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1167\/iovs.08-2536","article-title":"Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism","volume":"50","author":"Sugita","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cellimm.2016.09.009_b0660","first-page":"191","article-title":"Sj\u00f6gren\u2019s syndrome: current concepts","volume":"47","author":"Manoussakis","year":"2001","journal-title":"Adv. Intern. Med."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0665","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clin.1994.1123","article-title":"Sj\u00f6c; gren\u2019s Syndrome: Autoimmune Epithelitis","volume":"72","author":"Moutsopoulos","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"11","key":"10.1016\/j.cellimm.2016.09.009_b0670","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.152.11.5532","article-title":"Cytokine mRNA expression in salivary gland biopsies of Sj\u00f6gren\u2019s syndrome","volume":"152","author":"Fox","year":"1994","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0675","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0952-7915(01)00275-8","article-title":"Dendritic cells in autoimmune diseases","volume":"13","author":"Ludewig","year":"2001","journal-title":"Curr. Opin. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2016.09.009_b0680","first-page":"2156","article-title":"Enhanced expression of programmed death-1 (PD-1)\/PD-L1 in salivary glands of patients with Sj\u00f6gren\u2019s syndrome","volume":"32","author":"Kobayashi","year":"2005","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0685","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1074-7613(04)00051-2","article-title":"Structural and functional analysis of the costimulatory receptor programmed death-1","volume":"20","author":"Zhang","year":"2004","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cellimm.2016.09.009_b0690","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/intimm\/10.10.1563","article-title":"Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses","volume":"10","author":"Nishimura","year":"1998","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0695","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/art.24227","article-title":"Genetic, immunologic, and immunohistochemical analysis of the programmed death 1\/programmed death ligand 1 pathway in human systemic lupus erythematosus","volume":"60","author":"Bertsias","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0700","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0961203308099176","article-title":"Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus","volume":"18","author":"Her","year":"2009","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.cellimm.2016.09.009_b0705","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/rheumatology\/ken256","article-title":"Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1","volume":"47","author":"Mozaffarian","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.cellimm.2016.09.009_b0710","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/406136","article-title":"Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus","volume":"2009","author":"Liu","year":"2009","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0715","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.25032","article-title":"Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus","volume":"62","author":"Simpson","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0720","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/art.27417","article-title":"Lower expression levels of the programmed death 1 receptor on CD4+ CD25+ T cells and correlation with the PD-1.3 A genotype in patients with systemic lupus erythematosus","volume":"62","author":"Kristjansdottir","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.cellimm.2016.09.009_b0725","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nm955","article-title":"Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice","volume":"9","author":"Okazaki","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2016.09.009_b0730","first-page":"dxq026","article-title":"PD-1 deficiency results in the development of fatal myocarditis in MRL mice","author":"Wang","year":"2010","journal-title":"Int. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0735","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.4049\/jimmunol.181.4.2513","article-title":"Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice","volume":"181","author":"Lucas","year":"2008","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cellimm.2016.09.009_b0740","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.4049\/jimmunol.1200389","article-title":"PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis","volume":"188","author":"Tarrio","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0745","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI9295","article-title":"CD8+ T-cell autoreactivity to an HLA-B27\u2013restricted self-epitope correlates with ankylosing spondylitis","volume":"106","author":"Fiorillo","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cellimm.2016.09.009_b0750","article-title":"Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy","volume":"2012","author":"Szalay","year":"2011","journal-title":"Clin. Dev. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2016.09.009_b0755","doi-asserted-by":"crossref","first-page":"e107086","DOI":"10.1371\/journal.pone.0107086","article-title":"Decreased frequencies of circulating follicular helper T cell counterparts and plasmablasts in ankylosing spondylitis patients na\u00efve for TNF blockers","volume":"9","author":"Bautista-Caro","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cellimm.2016.09.009_b0760","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3899\/jrheum.130125","article-title":"Higher frequency of peripheral blood interleukin 21 positive follicular helper T cells in patients with ankylosing spondylitis","volume":"40","author":"Xiao","year":"2013","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.cellimm.2016.09.009_b0765","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s10067-011-1721-6","article-title":"Inverse correlation of programmed death 1 (PD-1) expression in T cells to the spinal radiologic changes in Taiwanese patients with ankylosing spondylitis","volume":"30","author":"Chen","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0770","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(00)00027-3","article-title":"Spontaneous autoimmune disease in Fc\u03b3RIIB-deficient mice results from strain-specific epistasis","volume":"13","author":"Bolland","year":"2000","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0775","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9","article-title":"PD-1: PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2","volume":"32","author":"Carter","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0780","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PPO.0000000000000060","article-title":"PD-1 as an Immune Modulatory Receptor","volume":"20","author":"Yao","year":"2014","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0785","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0961203308093923","article-title":"Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis","volume":"18","author":"Lee","year":"2009","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0790","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng1020","article-title":"A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans","volume":"32","author":"Prokunina","year":"2002","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0795","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.20966","article-title":"A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese","volume":"52","author":"Kong","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0800","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.20514","article-title":"A PD-1 polymorphism is associated with disease progression in multiple sclerosis","volume":"58","author":"Kroner","year":"2005","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0805","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/art.20040","article-title":"Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus","volume":"50","author":"Lin","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0810","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1186\/ar2071","article-title":"Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population","volume":"8","author":"Lee","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0815","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00296-009-1264-1","article-title":"Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population","volume":"31","author":"Liu","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0820","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1399-0039.2003.00136.x","article-title":"Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes","volume":"62","author":"Nielsen","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.cellimm.2016.09.009_b0825","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/ar1203","article-title":"Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus","volume":"6","author":"Alarc\u00f3n-Riquelme","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.cellimm.2016.09.009_b0830","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1464-5491.2007.02297.x","article-title":"No evidence of association of the PDCD1 gene with Type 1 diabetes","volume":"24","author":"Fawwaz","year":"2007","journal-title":"Diabet. Med."},{"issue":"8","key":"10.1016\/j.cellimm.2016.09.009_b0835","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/art.20436","article-title":"Association of PDCD1 with susceptibility to systemic lupus erythematosus","volume":"50","author":"Ferreiros-Vidal","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellimm.2016.09.009_b0840","first-page":"1","article-title":"PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus","author":"Mahmoudi","year":"2015","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0845","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/art.20280","article-title":"Association of the PD-1.3 A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope","volume":"50","author":"Prokunina","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0850","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10038-007-0145-2","article-title":"Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population","volume":"52","author":"Iwamoto","year":"2007","journal-title":"J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0855","first-page":"763","article-title":"Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients","volume":"29","author":"Tahoori","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0860","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/03009740701824613","article-title":"Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation","volume":"37","author":"Pedersen","year":"2008","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0865","first-page":"13","article-title":"Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population","volume":"29","author":"Yang","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0870","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10753-010-9282-4","article-title":"Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis","volume":"34","author":"Soleimanifar","year":"2011","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0875","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00776-014-0648-6","article-title":"The programmed cell death 1 gene polymorphisms (PD 1.3 G\/A, PD 1.5 C\/T and PD 1.9 C\/T) and susceptibility to ankylosing spondylitis: a meta-analysis","volume":"20","author":"Yang","year":"2014","journal-title":"J. Orthop. Sci."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0880","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10815-014-0371-4","article-title":"Association between a PD-1 gene polymorphism and antisperm antibody-related infertility in Iranian men","volume":"32","author":"Zamani","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0885","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.gene.6364223","article-title":"PDCD1: a tissue-specific susceptibility locus for inherited inflammatory disorders","volume":"6","author":"James","year":"2005","journal-title":"Genes Immun."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0890","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0002-9378(88)90037-3","article-title":"Autoantibodies and common idiotypes in men and women with sperm antibodies","volume":"158","author":"El-Roeiy","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0895","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.4049\/jimmunol.174.4.1888","article-title":"Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand","volume":"174","author":"Hirata","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2016.09.009_b0900","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2002-07-2254","article-title":"Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells","volume":"101","author":"Senju","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0905","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2005.10.017","article-title":"Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice","volume":"118","author":"Ding","year":"2006","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0910","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/art.33354","article-title":"Evidence for gene\u2013gene epistatic interactions among susceptibility loci for systemic lupus erythematosus","volume":"64","author":"Hughes","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cellimm.2016.09.009_b0915","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10875-006-9048-9","article-title":"Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan","volume":"26","author":"Wang","year":"2006","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0920","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.gene.6364383","article-title":"Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort","volume":"8","author":"Thorburn","year":"2007","journal-title":"Genes Immun."},{"issue":"4","key":"10.1016\/j.cellimm.2016.09.009_b0925","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1468-3083.2009.03087.x","article-title":"Association between the PD1. 3A\/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta-analysis","volume":"23","author":"Liu","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0930","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.gene.6364360","article-title":"No evidence of association between genetic variants of the PDCD1 ligands and SLE","volume":"8","author":"Abelson","year":"2007","journal-title":"Genes Immun."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0935","first-page":"543","article-title":"Programmed cell death 1 (PDCD1) gene polymorphisms and type 1 diabetes in Chilean children","volume":"138","author":"Flores","year":"2010","journal-title":"Rev. Med. Chil."},{"issue":"5","key":"10.1016\/j.cellimm.2016.09.009_b0940","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1744-313X.2010.00935.x","article-title":"PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients","volume":"37","author":"Fichna","year":"2010","journal-title":"Int. J. Immunogenet."},{"issue":"2","key":"10.1016\/j.cellimm.2016.09.009_b0945","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00439-006-0309-8","article-title":"PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children","volume":"121","author":"Ni","year":"2007","journal-title":"Hum. Genet."},{"issue":"3","key":"10.1016\/j.cellimm.2016.09.009_b0950","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.diabres.2008.12.003","article-title":"Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes","volume":"83","author":"Momin","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.cellimm.2016.09.009_b0955","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2350-8-71","article-title":"The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes","volume":"8","author":"Cooper","year":"2007","journal-title":"BMC Med. Genet."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874916301095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874916301095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:55:46Z","timestamp":1757804146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874916301095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":191,"alternative-id":["S0008874916301095"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2016.09.009","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1\/PD-L and autoimmunity: A growing relationship","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2016.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}